Clinical Data
Ablate AF Trial
Clinical trial to evaluate the safety and efficacy of the Isolator Synergy™ Ablation System™
Trial Outcomes (n=57 at 6 months)4
00%
FREE
of Afib
(48/57)
00%
FREE
of Afib
and off Antiarrhythmic Drugs (AAD)
(43/57)
INCLUSION CRITERIA FOR ABLATE / ABLATE AF TRIAL
History of permanent Afib in which cardioversion (electrical and/or pharmacologic) has failed or has not been attempted (as defined by the 2006 ACC/AHA/ESC Guidelines)
≥18 years of age
Scheduled to undergo elective cardiac surgical procedure(s) to be performed on cardiopulmonary bypass
Left ventricular ejection fraction ≥ 30%